Cytiva expanded its collaboration with Culture Biosciences, which specializes in cloud-connected bioreactor technology, to include both hardware commercialization and technology development. Building ...
Pierre-Alain Ruffieux, Cytiva’s group executive, bioprocess, discusses completion of the doubling of the company’s liquid ...
Since acquiring Cytiva from General Electric for $21.4 billion in 2019, the Danaher Corporation has laid out an ambitious expansion plan for the therapeutics developer and manufacturer. Now one of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results